Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT05600179

OCTA in Epivascular Glia After Dex Implant

Conditions: Diabetic Retinopathy

Sex: All

Ages: 18 Years – 80 Years

Healthy volunteers: 1

Enrollment: 38

Sponsor: Federico II University

Location: Italy

Summary

The aim of this prospective study was for the first time, to analyze specific morphologic features in diabetic eyes with macular oedema, such as changes of the foveal avascular zone and the presence of epivascular glia, and see how they would change after dexamethasone intravitreal implant

Eligibility Criteria

Inclusion Criteria:diabetic retinopathy complicated by macular edemaExclusion Criteria:congenital eye disorders,previous diagnosis of other ocular diseaseshistory of vitreous hemorrhage

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05600179). StuddyBuddy aggregates publicly available trial information.